The purpose of this study was to develop a tipranavir-weighted mutation score that provides guidance to treating physicians on the relative effect of specific protease mutations on tipranavir activity.
Schapiro, J., Scherer, J., Boucher, C., Baxter, J., Tilke, C., Perno, C.f., et al. (2010). Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score. ANTIVIRAL THERAPY, 15(7), 1011-1019 [10.3851/IMP1670].
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score
PERNO, CARLO FEDERICO;SANTORO, MARIA;
2010-01-01
Abstract
The purpose of this study was to develop a tipranavir-weighted mutation score that provides guidance to treating physicians on the relative effect of specific protease mutations on tipranavir activity.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Improving the prediction of virological response to tipranavir the development and validation of a tipranavir weighted mutation score Antiviral Therapy.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
253.49 kB
Formato
Adobe PDF
|
253.49 kB | Adobe PDF | Visualizza/Apri |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
